is reporting from
Member
NP Rank:
NP Rank:
On a steamy July morning in New York City last summer, Allergan, maker of Botox, unveiled the latest weapon in its aesthetic arsenal, Juvéderm. The new wrinkle filler--made from hyaluronic acid, a naturally occurring sugar in the skin that helps it hold moisture--had just got the green light from the FDA for distribution in the U.S. Champagne corks popped and a curtain parted to reveal a glamorous and wrinkle-free blond, seen minutes before on a video with a face full of creases and frowns. "This is the new generation of dermal fillers," gushed Caroline Van Hove, director of communications for Allergan. "Juvéderm is going to rock the market."
Comments (0)